Intellectual Property India Publishes Patent Application for Compositions Comprising Pralatrexate For Subcutaneous Administration And Methods Of Use Thereof

MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617037025 A) filed by Acrotech Biopharma Inc.; Dileep, Jami; and Dastagiri, Madduru on March 26, 2026, for Compositions Comprising Pralatrexate For Subcutaneous Administration And Methods Of Use Thereof.

Inventors include Anvekar, Ashish; Dileep, Jami; Dastagiri, Madduru; Jana, Arun; Vishnubhotla, Nagaprasad; and Sivakumaran, Meenakshisunderam.

The application for the patent was published on June 19, 2026, under issue no. 25/2026.

Abstract: The present disclosure provides compositions comprising Pralatrexate for subcutaneous administration. The present disclosure also provides methods of administering the compositions comprising Pralatrexate, as disclosed herein, for the treatment of disease (e.g., lymphoma).

Disclaimer: Curated by HT Syndication.